It binds to plasminogen 2ε in the prostate cancer cell line 1-LN, triggering an intracellular [Ca2+] flux leading to the upregulation of MMP-9 (Gonzalez-Gronow et al, 2001). The gene discussed is MMP9; the disease is prostate carcinoma.